Condensate biology: advancing drug discovery for complex diseases
Drug Target Review
JULY 13, 2023
Dewpoint Therapeutics, a platform drug discovery company founded in 2018, has been at the forefront of this exciting field. Dewpoint’s breakthrough was the realisation that certain condensates are associated with human diseases. The aim is to establish condensate biology as a fundamental branch of cell biology – “cell biology 2.0”
Let's personalize your content